Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10965037 | Vaccine | 2014 | 7 Pages |
Abstract
This research yielded the most comprehensive real cost estimates of HPV vaccination yet published for sub-Saharan Africa. Our models indicate that HPV vaccination in Mali will be cost-effective when introduced. To maximize the benefit using limited resources, vaccination programs may begin with a target coverage of about 50%. We anticipate that costs of reaching late adopters after the First Vaccinated Wave of vaccination will be higher, but worthwhile.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
J. Kathleen Tracy, Nicholas H. Schluterman, Christina Greene, Samba O. Sow, Holly D. Gaff,